{"id":24066,"date":"2025-10-01T14:55:13","date_gmt":"2025-10-01T18:55:13","guid":{"rendered":"https:\/\/thespanishmedia.com\/?p=24066"},"modified":"2025-10-01T14:55:13","modified_gmt":"2025-10-01T18:55:13","slug":"canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer","status":"publish","type":"post","link":"https:\/\/thespanishmedia.com\/fr\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/","title":{"rendered":"Canad\u00e1, \u00fanico pa\u00eds del G7 sin acceso a nuevos f\u00e1rmacos contra el Alzheimer"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Dos medicamentos que han demostrado ralentizar la progresi\u00f3n del Alzheimer en fase temprana a\u00fan no est\u00e1n disponibles en Canad\u00e1, lo que convierte al pa\u00eds en el \u00fanico miembro del G7 que no ha autorizado su uso. Se trata de <\/span><i><span style=\"font-weight: 400;\">lecanemab<\/span><\/i><span style=\"font-weight: 400;\"> y <\/span><i><span style=\"font-weight: 400;\">donanemab<\/span><\/i><span style=\"font-weight: 400;\">, terapias aprobadas en pa\u00edses como Estados Unidos, Jap\u00f3n y Australia, que representan el primer avance significativo tras d\u00e9cadas de investigaci\u00f3n con resultados negativos.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Ambos f\u00e1rmacos act\u00faan eliminando las placas de amiloide en el cerebro, una prote\u00edna vinculada con el desarrollo de la enfermedad. Los ensayos cl\u00ednicos han mostrado que los pacientes tratados experimentan un deterioro cognitivo alrededor de un 30% m\u00e1s lento en comparaci\u00f3n con quienes recibieron placebos, lo que equivale a entre cinco y seis meses adicionales de vida independiente.<\/span><\/p>\n<h2><b>Demoras regulatorias y cuestionamientos sobre el costo<\/b><\/h2>\n<p><i><span style=\"font-weight: 400;\">Health Canada<\/span><\/i><span style=\"font-weight: 400;\"> lleva m\u00e1s de dos a\u00f1os revisando estas terapias, pero hasta el momento no ha emitido una aprobaci\u00f3n. La entidad reguladora ha se\u00f1alado que solo autoriza medicamentos cuando los beneficios superan los riesgos, dado que ambos presentan efectos secundarios como n\u00e1useas, dolor de cabeza y, en casos poco frecuentes, inflamaci\u00f3n o sangrado cerebral.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Otro desaf\u00edo es el costo. En Estados Unidos, el <\/span><i><span style=\"font-weight: 400;\">lecanemab<\/span><\/i><span style=\"font-weight: 400;\"> se comercializa en 26.500 d\u00f3lares anuales y el <\/span><i><span style=\"font-weight: 400;\">donanemab<\/span><\/i><span style=\"font-weight: 400;\"> en 32.000 d\u00f3lares, sin contar los gastos adicionales asociados a las infusiones intravenosas y los esc\u00e1neres cerebrales necesarios para su monitoreo. En el Reino Unido, el Instituto Nacional para la Excelencia en la Salud y la Atenci\u00f3n (NICE) ya rechaz\u00f3 el <\/span><i><span style=\"font-weight: 400;\">donanemab<\/span><\/i><span style=\"font-weight: 400;\"> argumentando que su beneficio cl\u00ednico no justifica el alto precio.<\/span><\/p>\n<h2><b>Perspectivas y retos para el sistema de salud canadiense<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">En caso de ser autorizados, los medicamentos no estar\u00e1n disponibles para todos los pacientes, sino \u00fanicamente para quienes se encuentren en las primeras etapas de la enfermedad. Esto plantea un debate en torno al acceso equitativo y la capacidad del sistema de salud para costear terapias de alto valor pero alcance limitado.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">La Sociedad Canadiense de Alzheimer estima que para 2030 cerca de un mill\u00f3n de personas en el pa\u00eds vivir\u00e1n con alg\u00fan tipo de demencia, lo que refuerza la necesidad de inversiones en prevenci\u00f3n, diagn\u00f3stico temprano y educaci\u00f3n sobre los factores de riesgo modificables. El retraso en la aprobaci\u00f3n de nuevos tratamientos mantiene el foco en la urgencia de acelerar procesos regulatorios y garantizar opciones terap\u00e9uticas que puedan cambiar el curso de la enfermedad en los pr\u00f3ximos a\u00f1os.<\/span><\/p>\n<p><b>Redacci\u00f3n de: <\/b><span style=\"font-weight: 400;\">Karen Rodr\u00edguez A.<\/span><b>\u00a0<\/b><\/p>","protected":false},"excerpt":{"rendered":"<p>Dos medicamentos que han demostrado ralentizar la progresi\u00f3n del Alzheimer en fase temprana a\u00fan no est\u00e1n disponibles en Canad\u00e1, lo que convierte al pa\u00eds en el \u00fanico miembro del G7 que no ha autorizado su uso. Se trata de lecanemab y donanemab, terapias aprobadas en pa\u00edses como Estados Unidos, Jap\u00f3n y Australia, que representan el [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":24071,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_glsr_average":0,"_glsr_ranking":0,"_glsr_reviews":0,"footnotes":""},"categories":[6968],"tags":[5628,5634,9184,1820,5126,224,9185,32,987,204],"class_list":["post-24066","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pasaporte-a-canada","tag-alzheimer","tag-enfermedadesneurodegenerativas","tag-farmacos","tag-g7","tag-innovacionmedica","tag-saludpublica","tag-tratamientos","tag-canada","tag-medicina","tag-salud"],"blocksy_meta":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.2 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Canad\u00e1, \u00fanico pa\u00eds del G7 sin acceso a nuevos f\u00e1rmacos contra el Alzheimer - The Spanish Media<\/title>\n<meta name=\"description\" content=\"Dos medicamentos que han demostrado ralentizar la progresi\u00f3n del Alzheimer en fase temprana a\u00fan no est\u00e1n disponibles en Canad\u00e1\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/thespanishmedia.com\/fr\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Canad\u00e1, \u00fanico pa\u00eds del G7 sin acceso a nuevos f\u00e1rmacos contra el Alzheimer\" \/>\n<meta property=\"og:description\" content=\"Dos medicamentos que han demostrado ralentizar la progresi\u00f3n del Alzheimer en fase temprana a\u00fan no est\u00e1n disponibles en Canad\u00e1\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thespanishmedia.com\/fr\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/\" \/>\n<meta property=\"og:site_name\" content=\"The Spanish Media\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/thespanishmedia.ca\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-01T18:55:13+00:00\" \/>\n<meta name=\"author\" content=\"The Spanish Media\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"The Spanish Media\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\\\/\"},\"author\":{\"name\":\"The Spanish Media\",\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/#\\\/schema\\\/person\\\/cdfd443208fa68f9cec21cb44a66c134\"},\"headline\":\"Canad\u00e1, \u00fanico pa\u00eds del G7 sin acceso a nuevos f\u00e1rmacos contra el Alzheimer\",\"datePublished\":\"2025-10-01T18:55:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\\\/\"},\"wordCount\":449,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"#Alzheimer\",\"#EnfermedadesNeurodegenerativas\",\"#F\u00e1rmacos\",\"#G7\",\"#Innovaci\u00f3nM\u00e9dica\",\"#SaludP\u00fablica\",\"#Tratamientos\",\"Canada\",\"medicina\",\"salud\"],\"articleSection\":[\"Pasaporte a Canad\u00e1\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/thespanishmedia.com\\\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\\\/\",\"url\":\"https:\\\/\\\/thespanishmedia.com\\\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\\\/\",\"name\":\"Canad\u00e1, \u00fanico pa\u00eds del G7 sin acceso a nuevos f\u00e1rmacos contra el Alzheimer - The Spanish Media\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2025-10-01T18:55:13+00:00\",\"description\":\"Dos medicamentos que han demostrado ralentizar la progresi\u00f3n del Alzheimer en fase temprana a\u00fan no est\u00e1n disponibles en Canad\u00e1\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/thespanishmedia.com\\\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\\\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/thespanishmedia.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Canad\u00e1, \u00fanico pa\u00eds del G7 sin acceso a nuevos f\u00e1rmacos contra el Alzheimer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/#website\",\"url\":\"https:\\\/\\\/thespanishmedia.com\\\/\",\"name\":\"The Spanish Media\",\"description\":\"Noticias en espa\u00f1ol, inmigraci\u00f3n y settlement en Canad\u00e1.\",\"publisher\":{\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/thespanishmedia.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/#organization\",\"name\":\"The Spanish Media\",\"url\":\"https:\\\/\\\/thespanishmedia.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/thespanishmedia.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Logo-Horizontal.png\",\"contentUrl\":\"https:\\\/\\\/thespanishmedia.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Logo-Horizontal.png\",\"width\":1840,\"height\":720,\"caption\":\"The Spanish Media\"},\"image\":{\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/thespanishmedia.ca\",\"https:\\\/\\\/www.instagram.com\\\/thespanishmedia.ca\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@TheSpanishMedia-\",\"https:\\\/\\\/www.tiktok.com\\\/@thespanishmedia\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/thespanishmedia.com\\\/#\\\/schema\\\/person\\\/cdfd443208fa68f9cec21cb44a66c134\",\"name\":\"The Spanish Media\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4a6f15b35b39a16d5773702f6e938298774ef701109a0e7fb8d3a3e34f260f3a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4a6f15b35b39a16d5773702f6e938298774ef701109a0e7fb8d3a3e34f260f3a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4a6f15b35b39a16d5773702f6e938298774ef701109a0e7fb8d3a3e34f260f3a?s=96&d=mm&r=g\",\"caption\":\"The Spanish Media\"},\"url\":\"https:\\\/\\\/thespanishmedia.com\\\/fr\\\/author\\\/media\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Canad\u00e1, \u00fanico pa\u00eds del G7 sin acceso a nuevos f\u00e1rmacos contra el Alzheimer - The Spanish Media","description":"Dos medicamentos que han demostrado ralentizar la progresi\u00f3n del Alzheimer en fase temprana a\u00fan no est\u00e1n disponibles en Canad\u00e1","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/thespanishmedia.com\/fr\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/","og_locale":"fr_FR","og_type":"article","og_title":"Canad\u00e1, \u00fanico pa\u00eds del G7 sin acceso a nuevos f\u00e1rmacos contra el Alzheimer","og_description":"Dos medicamentos que han demostrado ralentizar la progresi\u00f3n del Alzheimer en fase temprana a\u00fan no est\u00e1n disponibles en Canad\u00e1","og_url":"https:\/\/thespanishmedia.com\/fr\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/","og_site_name":"The Spanish Media","article_publisher":"https:\/\/www.facebook.com\/thespanishmedia.ca","article_published_time":"2025-10-01T18:55:13+00:00","author":"The Spanish Media","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"The Spanish Media","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thespanishmedia.com\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/#article","isPartOf":{"@id":"https:\/\/thespanishmedia.com\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/"},"author":{"name":"The Spanish Media","@id":"https:\/\/thespanishmedia.com\/#\/schema\/person\/cdfd443208fa68f9cec21cb44a66c134"},"headline":"Canad\u00e1, \u00fanico pa\u00eds del G7 sin acceso a nuevos f\u00e1rmacos contra el Alzheimer","datePublished":"2025-10-01T18:55:13+00:00","mainEntityOfPage":{"@id":"https:\/\/thespanishmedia.com\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/"},"wordCount":449,"commentCount":0,"publisher":{"@id":"https:\/\/thespanishmedia.com\/#organization"},"image":{"@id":"https:\/\/thespanishmedia.com\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/#primaryimage"},"thumbnailUrl":"","keywords":["#Alzheimer","#EnfermedadesNeurodegenerativas","#F\u00e1rmacos","#G7","#Innovaci\u00f3nM\u00e9dica","#SaludP\u00fablica","#Tratamientos","Canada","medicina","salud"],"articleSection":["Pasaporte a Canad\u00e1"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thespanishmedia.com\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thespanishmedia.com\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/","url":"https:\/\/thespanishmedia.com\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/","name":"Canad\u00e1, \u00fanico pa\u00eds del G7 sin acceso a nuevos f\u00e1rmacos contra el Alzheimer - The Spanish Media","isPartOf":{"@id":"https:\/\/thespanishmedia.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thespanishmedia.com\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/#primaryimage"},"image":{"@id":"https:\/\/thespanishmedia.com\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/#primaryimage"},"thumbnailUrl":"","datePublished":"2025-10-01T18:55:13+00:00","description":"Dos medicamentos que han demostrado ralentizar la progresi\u00f3n del Alzheimer en fase temprana a\u00fan no est\u00e1n disponibles en Canad\u00e1","breadcrumb":{"@id":"https:\/\/thespanishmedia.com\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thespanishmedia.com\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/thespanishmedia.com\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/thespanishmedia.com\/canada-unico-pais-del-g7-sin-acceso-a-nuevos-farmacos-contra-el-alzheimer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/thespanishmedia.com\/"},{"@type":"ListItem","position":2,"name":"Canad\u00e1, \u00fanico pa\u00eds del G7 sin acceso a nuevos f\u00e1rmacos contra el Alzheimer"}]},{"@type":"WebSite","@id":"https:\/\/thespanishmedia.com\/#website","url":"https:\/\/thespanishmedia.com\/","name":"Les M\u00e9dias Espagnols","description":"Noticias en espa\u00f1ol, inmigraci\u00f3n y de r\u00e8glement en Canad\u00e1.","publisher":{"@id":"https:\/\/thespanishmedia.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thespanishmedia.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/thespanishmedia.com\/#organization","name":"Les M\u00e9dias Espagnols","url":"https:\/\/thespanishmedia.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/thespanishmedia.com\/#\/schema\/logo\/image\/","url":"https:\/\/thespanishmedia.com\/wp-content\/uploads\/2026\/08\/Logo-Horizontal.png","contentUrl":"https:\/\/thespanishmedia.com\/wp-content\/uploads\/2026\/08\/Logo-Horizontal.png","width":1840,"height":720,"caption":"The Spanish Media"},"image":{"@id":"https:\/\/thespanishmedia.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/thespanishmedia.ca","https:\/\/www.instagram.com\/thespanishmedia.ca\/","https:\/\/www.youtube.com\/@TheSpanishMedia-","https:\/\/www.tiktok.com\/@thespanishmedia"]},{"@type":"Person","@id":"https:\/\/thespanishmedia.com\/#\/schema\/person\/cdfd443208fa68f9cec21cb44a66c134","name":"Les M\u00e9dias Espagnols","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/4a6f15b35b39a16d5773702f6e938298774ef701109a0e7fb8d3a3e34f260f3a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4a6f15b35b39a16d5773702f6e938298774ef701109a0e7fb8d3a3e34f260f3a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4a6f15b35b39a16d5773702f6e938298774ef701109a0e7fb8d3a3e34f260f3a?s=96&d=mm&r=g","caption":"The Spanish Media"},"url":"https:\/\/thespanishmedia.com\/fr\/author\/media\/"}]}},"_links":{"self":[{"href":"https:\/\/thespanishmedia.com\/fr\/wp-json\/wp\/v2\/posts\/24066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thespanishmedia.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thespanishmedia.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thespanishmedia.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/thespanishmedia.com\/fr\/wp-json\/wp\/v2\/comments?post=24066"}],"version-history":[{"count":0,"href":"https:\/\/thespanishmedia.com\/fr\/wp-json\/wp\/v2\/posts\/24066\/revisions"}],"wp:attachment":[{"href":"https:\/\/thespanishmedia.com\/fr\/wp-json\/wp\/v2\/media?parent=24066"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thespanishmedia.com\/fr\/wp-json\/wp\/v2\/categories?post=24066"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thespanishmedia.com\/fr\/wp-json\/wp\/v2\/tags?post=24066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}